TOI appoints Mark Stolper to Board as Audit Committee Chairman

Oncology Institute, Inc.

Mark D. Stolper appointed to Board effective Jan 2, 2026; fills a vacancy.
Stolper is CFO of RadNet (RDNT) with prior oncology board experience.
Appointed Audit Committee Chairman and designated financial expert.
Will receive $75,000 annual retainer and future RSU grant for board service.
Term expires at next annual meeting; expected to be nominated for re-election.

item 5.02 item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001079973-26-000051
form_type: 8-K
ticker: TOI
cik: 0001799191
company_name: Oncology Institute, Inc.
filed_at: 2026-01-07T23:59:59+00:00
discovered_at: 2026-05-14T18:02:36.212602+00:00
generated_at: 2026-05-16T11:23:44.656399+00:00
sec_items: ["5.02", "7.01", "9.01"]
event_type: leadership
sentiment: neutral
materiality_score: 0.35
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001079973-26-000051
json_url: https://secwatch.observer/filing/0001079973-26-000051.json
markdown_url: https://secwatch.observer/filing/0001079973-26-000051.md
text_url: https://secwatch.observer/filing/0001079973-26-000051.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1799191/000107997326000051/0001079973-26-000051-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1799191/000107997326000051/toi_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001079973-26-000051

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.